Published in Medical Letter on the CDC and FDA, August 13th, 2006
"Protective immunity against Plasmodium falciparum is partially mediated through binding of malaria-specific IgG antibodies to Fc gamma receptors. Polymorphic variability in Fc gamma RIIa (H/R-131) is associated with differential binding of IgG subtypes and malaria disease outcomes. However, the role of Fc gamma RIIa-131 variability in conditioning susceptibility to severe malarial anemia, the primary manifestation...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.